Orthopedics in Minnesota

Sonex Health develops ultrasound-guided minimally invasive surgical solutions for musculoskeletal (MSK) procedures, focusing on carpal tunnel release and trigger finger release. The company's technology enables physicians to perform these procedures in office or procedure room settings using real-time ultrasound guidance, local anesthesia, and minimal incisions typically closed without sutures. Clinical evidence demonstrates faster patient recovery—return to normal activities within days rather than weeks—compared to traditional endoscopic approaches. Sonex Health operates the Institute of Advanced Ultrasound Guided Procedures, providing comprehensive professional education including self-guided web-based training, educational webinars, on-site cadaver training programs, and access to a state-of-the-art training laboratory. The company has completed patient enrollment in randomized controlled clinical trials (TUTOR study) and published real-world outcome data in peer-reviewed journals (Journal of Hand Surgery Global Online, MISSION Registry). Products are designed on the principle of "refined simplicity," delivering elegant, effective solutions for hand and wrist surgical interventions. The company serves orthopedic surgeons, hand surgeons, and other physicians seeking minimally invasive alternatives to traditional open or endoscopic techniques. Sonex Health is positioned as both a medical device and education/training provider in the growing field of ultrasound-guided surgical procedures.

Medical Surgical Inc. is a specialized orthopedic surgical device manufacturer focused on anterior cruciate ligament (ACL) reconstruction fixation systems. The company has been producing the proprietary Goal Post fixation system for over 20 years, serving academic medical centers, orthopedic specialty hospitals, and health systems across the United States. The Goal Post system is designed for ACL graft fixation during arthroscopic anterior cruciate ligament repair procedures. The company's customer base includes prestigious orthopedic institutions such as The Andrews Institute, Bon Secours St. Francis Health System, University of Connecticut Health Center, University of Iowa Healthcare, St. Vincent's Hospital, University of Wisconsin Health, and Mission Hospital. Medical Surgical Inc. operates from Andover, Minnesota, and maintains specialized manufacturing capabilities for orthopedic surgical instrumentation. The company serves orthopedic surgeons and surgical centers performing ACL reconstruction procedures.

MeKo Manufacturing e.K. is a contract manufacturer of precision medical components and implants for the interventional and surgical device industry. Founded in 1995, the company pioneered stent manufacturing and is now among the largest contract manufacturers of medical components globally. MeKo specializes in laser cutting, laser welding, and advanced processing of materials including stainless steel (316L, 316LVM), cobalt alloys (L605, Phynox, MP35N), nitinol (NiTi), magnesium alloys (Resoloy®), nickel-free alloys (Vasculoy®), and polymers (PolyMediX®, PLLA, PGA). The company manufactures implants for cardiology, neurology, radiology, ophthalmology, and urology applications, with product lines including metal stents, NiTi stents, hypotubes, retrieval baskets, bone nails, heart valve frames, orthopedic devices, surgical instruments, microcomponents, and drug-delivery balloon catheters. Manufacturing capabilities include CAD/CAM design, precise laser cutting (tolerances below ±5 μm), laser welding, mechanical processing, heat treatment, shape setting, electropolishing, 3D metal printing, polymer coating, marker crimping, and rapid prototyping. The company operates ISO-certified quality management with 100% visual inspection using over 100 specialized high-end microscopes and maintains ISO 8 cleanrooms (Class 100,000). MeKo offers finite element analysis (FEA) simulation services, prototype-to-series production capabilities, and operates 24/7 manufacturing. The company maintains facilities in Germany (Sarstedt, near Hannover), the USA (Bloomington, Minnesota), California, and Costa Rica.

NeckCare develops objective assessment and rehabilitation systems for cervical spine dysfunction. The company manufactures the NeckCare System™, a wearable sensor device with Bluetooth connectivity paired with a web-based clinical platform, used by over 250 providers across North America to evaluate and treat patients with neck pain, headaches, concussion, whiplash-associated disorders, and dizziness. The system measures cervical range of motion, proprioception (joint position sense), and sensorimotor control through the proprietary Butterfly Test®. The NeckCare Platform automates assessment protocols, generates normative data comparisons, and enables real-time progress tracking. NeckCare Home™ is a camera-powered remote rehabilitation extension requiring no additional hardware beyond a standard personal device camera. The system is FDA-listed and incorporates decades of clinical research. Primary markets include physical therapy clinics, chiropractic practices, sports medicine facilities, and academic medical centers. The system generates objective documentation supporting clinical decision-making and insurance claim substantiation. Customers include University of Miami, Johns Hopkins Medicine, and UFC Performance Institute.

Winter Innovations is a medical device company specializing in advanced suturing solutions for orthopedic and sports medicine surgery. The company designs and manufactures patented surgical instruments focused on improving surgical efficiency and reducing tissue trauma. Their primary product, EasyWhip®, is a two-part needle system that enables multiple stitching techniques including standard whip stitch, the proprietary WhipLock™ stitch, and hybrid patterns. The WhipLock™ technique reduces needle passes by 50% versus traditional locking stitches while maintaining construct security and strength. Applications include distal biceps repair, peroneal tendon repair, Achilles tendon repair, and ACL graft preparation. The company also manufactures StitchStand™, a versatile graft preparation stand featuring integrated clamps for tissue stabilization during surgical procedures. Winter Innovations has published peer-reviewed research in the American Journal of Sports Medicine and Arthroscopy demonstrating biomechanical advantages of their WhipLock™ technique. The company has received recognition as a finalist for the 2025 MedTech Innovator Value Award and was awarded a $200K NSF TECP grant. Their technology is targeted at orthopedic surgeons, sports medicine specialists, and foot and ankle surgeons.

Tamarack Habilitation Technologies is an ISO 13485 certified manufacturer of innovative orthotic, prosthetic, and adaptive equipment. Founded in 1990, the company specializes in friction management and pressure injury prevention technologies designed to maximize comfort and mobility for people dependent on assistive devices. Core products include the Flexure Joint (a lightweight, durable articulation component used since 1995), GlideWear (a strategic friction-reduction material), ShearBan (self-adhesive low-friction interface), ENGO (blister-relief patches), FlexForm (customizable wheelchair seating for pressure injury treatment and prevention), and GlideFree (self-adhesive transfer board tape). These solutions address skin shear forces, reduce life-threatening pressure wound infections, and are used by clinicians worldwide in medical, athletic, veterinary, and wearable applications. Tamarack's mission centers on creating health, independence, and performance enhancements for people of all abilities.

Radux Devices Inc. is a Minnesota-based medical device manufacturer specializing in occupational health and safety solutions for interventional healthcare professionals. The company designs ergonomic tools and radiation protection devices for interventional cardiologists, radiologists, vascular medicine specialists, electrophysiologists, and pain management practitioners. Founded by Dr. Greg Gordon, Radux focuses on reducing scatter radiation exposure and musculoskeletal fatigue through innovative shielding and arm-support systems. Their product line addresses the critical gap between patient care and provider safety, offering cost-effective solutions that improve workflow efficiency and practitioner well-being across multiple medical disciplines including interventional cardiology, radiology, vascular medicine, electrophysiology, orthopedics, neurovascular procedures, and pain management.

McKie Splints designs and manufactures therapeutic splinting devices specializing in the thumb, wrist, and hand. The company offers neoprene thumb splints, supination straps, and custom wrist-hand orthotics with biomechanically aligned designs to assist weaker muscles during grasp and reach activities. Products are available in six colors and in sizes for infants, children, teenagers, and adults. McKie Splints are recommended by occupational therapists, physical therapists, and wrist/hand orthotists nationally and internationally. The company serves patients with conditions including arthritis, cerebral palsy, hemiplegia, multiple sclerosis, stroke, trigger thumb, tendonitis, and various neurological disorders. McKie Splints also offers splinting webinars and product consultations for OT & PT teams and healthcare organizations.

Hemostasis, LLC is a FDA-registered, ISO 13485:2016-certified medical device manufacturer specializing in advanced biomaterial-based hemostasis and wound-healing technologies. The company develops and manufactures innovative bleeding-control products utilizing pharmaceutical-grade NOCC chitosan polymer technology. Core offerings include PosiSep® branded hemostat dressings and intranasal splints for ENT sinus procedures, NexStat® and Accel® topical hemostatic powders, BleedArrest® foam sponges, BoneSeal® bone hemostats, and NexFoam® topical hemostat sponges. Products are designed for diverse surgical applications including sinus, cardiac, orthopedic, vascular, soft tissue, and solid organ procedures. The company provides custom manufacturing services for OEMs and maintains active research and development capabilities in bleeding control technologies.

Kneewell is an FDA-registered, patented medical device designed to help total knee replacement (TKA) and knee contracture patients recover faster by achieving greater knee extension with reduced pain. The device employs three-point Static Progressive Stretch (SPS) therapy principles, enabling patients to augment in-person physical therapy sessions from home. Its bilateral, adjustable design accommodates patients of all sizes, with patient-controlled ratchet mechanism for stretch intensity regulation. The device features a quick-release mechanism for ease of use and is assigned HCPCS code E1811, making it eligible for third-party reimbursement. Kneewell is distributed through a network of partner surgeons, physical therapists, and clinical providers, offering healthcare professionals a research-backed adjunctive therapy tool to improve post-operative knee surgery outcomes.

NorthStar Surgical, Inc. is a specialty surgical products distributor and manufacturer's representative group serving the Upper Midwest, including Minnesota, North Dakota, South Dakota, Wisconsin, Iowa, and Nebraska. The company provides surgical products and solutions across multiple surgical specialties: Cardiac, ENT (Otorhinolaryngology), General Surgery, Gynecological, Neurosurgery, Orthopedic, Plastic Surgery, Vascular, and Urological Surgery. NorthStar's sales force brings over 100 years of combined experience in specialty surgical product sales and distribution. The company operates as both a direct distributor and rep group, positioning itself as a regional leader in the specialty surgical market. Based in Edina, Minnesota, NorthStar serves hospitals, surgical centers, and physician practices throughout the region. The company maintains direct sales support, customer service, and operations management to facilitate orders, technical support, and relationship management with healthcare facilities.

Marrow Access Technologies is a medtech company specializing in minimally invasive orthopedic surgical solutions for cartilage repair and regeneration. The company's flagship product, the SmartShot marrow access device, was launched in 2021 and represents an advancement over traditional microfracture techniques. The SmartShot device creates precise microchannels that provide superior access to stem cell-rich bone marrow with significantly less disruption to native bone structure. Clinical data demonstrates 2X greater marrow exposure and 66% less bone disruption compared to conventional mallet-based microfracture. The device is suitable for various weight-bearing joints including the knee, hip, and ankle, and can be used for standalone marrow stimulation therapy or in combination with biological agents. A specialized SmartShot Ankle device addresses the unique anatomical challenges of treating cartilage lesions in the ankle joint. The company partners with Spartan Medical to deliver cartilage repair therapy to U.S. military veterans and active Department of Defense service members.

Neuros Medical Inc. manufactures the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable neuromodulation device designed for chronic post-amputation pain management in adult lower limb amputees. The Altius system provides on-demand pain relief for phantom limb pain and residual limb pain through patient-controlled electrical stimulation delivered directly to affected nerves via an implantable pulse generator and wireless controller. The system enables patients to initiate therapy when needed without scheduled treatments. Clinical evidence from the QUEST study (180 patients) demonstrated significant therapeutic outcomes: 44% improvement in walking ability, 51% improvement in sleep quality, and 45% improvement in overall quality of life. Patients achieved approximately 30% pain reduction within 30 minutes of therapy initiation and approximately 50% pain reduction at 120 minutes. The device is indicated as an aid in managing chronic intractable phantom and residual lower limb post-amputation pain. FDA approval reflects successful demonstration of safety and effectiveness, though the agency imposed a post-market condition requiring human factors engineering and usability validation testing per FDA's 2016 guidance. The company markets directly to eligible amputees and coordinates with healthcare providers for surgical implantation and ongoing management. Contraindications include patient inability to operate the system and unsuitability for implant surgery. Key safety considerations include incompatibility with diathermy, potential electromagnetic interference, cardiac device interactions, contraindication for MRI/NMRI, and increased adverse event frequency in diabetic patients.